Financials
Financial year 2025
C.E.R. - CLINICAL ENGINEERING & RESEARCH from Sint-Martens-Latem, company number BE0425363905, closed financial year 2025 with a result of € 197,395 after tax. For that financial year C.E.R. - CLINICAL ENGINEERING & RESEARCH recorded a gross margin of € 1.2 million and equity of € 13.3 million. Compared with financial year 2024, the result moved from € 161,816 to € 197,395. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 26, 2026.
€ 13.3 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 197,395
▲ 22% vs 2024
Profit after tax over the fiscal year.
€ 529,062
▲ 113% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 300,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
2
▲ 1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 78,598
▲ 11% vs 2024
€ 39,300 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 11,417
▼ 1% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 15,002
▲ 141% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 43,360
▼ 20% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 1,153,993 | € 1,200,926 | ▲ 4% |
| Profit after taxes | € 161,816 | € 197,395 | ▲ 22% |
| Equity | € 13,451,513 | € 13,348,907 | ▼ 1% |
| Total debts | € 3,971,670 | € 3,641,345 | ▼ 8% |
| Cash | € 248,032 | € 529,062 | ▲ 113% |
| Retained profit | € 13,327,566 | € 13,224,960 | ▼ 1% |
| Dividend | € 400,000 | € 300,000 | ▼ 25% |
| Balance sheet total | € 17,581,775 | € 17,136,951 | ▼ 3% |
| Employees (FTE) | 1 | 2 | ▲ 1 |
Key figures of C.E.R. - CLINICAL ENGINEERING & RESEARCH, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to C.E.R. - CLINICAL ENGINEERING & RESEARCH?
What happened at C.E.R. - CLINICAL ENGINEERING & RESEARCH in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 197,395 (▲ 22% vs 2024). Source: NBB ↗
- New establishment in Sint-Martens-Latem. KBO
- Start of the company according to the CBE. KBO
In short
From € 161,816 profit in 2024 to € 197,395 profit in 2025.
Paid € 167,055 in corporate taxes since 2024.
Best year ever: 2025, with € 197,395 profit.
On average € 600,500 of value added per employee in 2025.
Management
Behind C.E.R. - CLINICAL ENGINEERING & RESEARCH are Jan RUYSSCHAERT and Lieve VANHOUTEGHEM. It owns 99.9% of L&J-Label itself.
Directors
According to the 2025 annual accounts
Jan RUYSSCHAERT
Director
Also active at: RESIDENZ, L&J - label, HEB, High 5 Investments, L&J Invest, Harvest, Heb Immo, Acasa Projects +2 more
Establishments
Establishment units
Physical locations of this company
Bogaertstraat 24
9830 Sint-Martens-Latem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 5 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0425.363.905
- VAT number
- BE 0425.363.905
- Registered office
- Bogaertstraat 24, 9830 Sint-Martens-Latem
- Names & denominations
- C.E.R. - CLINICAL ENGINEERING & RESEARCH
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 20 December 1983
- Peppol
- Active · Active since 16 Dec 2025
- Activities · NACE
Activiteiten van holdings
Managementactiviteiten van holdings
Holdings